BAX and B-cell chronic lymphocytic leukemia: The fold Bax activation, calculated as the ratio of the MFI of active Bax in treated versus untreated samples, was significantly higher in CLL cells compared to healthy B cells (Figure 3D), further witnessing to a higher sensitivity of CLL cells to GroPIns compared to healthy B cells.